Ado-trastuzumab emtansine and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Ado-trastuzumab emtansine and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Insulin degludec Subcutaneous
- Ado-trastuzumab emtansine-Insulin detemir
- Ado-trastuzumab emtansine-Insulin Detemir (Cartridges and Prefilled Syringes)
- Ado-trastuzumab emtansine-Insulin Detemir (Vials)
- Ado-trastuzumab emtansine-Insulin detemir Subcutaneous
- Ado-trastuzumab emtansine-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Ado-trastuzumab emtansine Intravenous
- Insulin degludec and liraglutide Subcutaneous-Adox Pak 2/100
- Insulin degludec and liraglutide Subcutaneous-Adoxa
- Insulin degludec and liraglutide Subcutaneous-Adoxa CK
- Insulin degludec and liraglutide Subcutaneous-Adoxa Pak
- Insulin degludec and liraglutide Subcutaneous-Adoxa Pak 1/100